From foundations to the future: building a new era in DVT managementHAAS, Sylvia; TURPIE, Alexander G. G.Blood coagulation & fibrinolysis. 1999, Vol 10, issn 0957-5235, 133 p., SUP2Conference Proceedings

Future prospects of prophylaxis for deep vein thrombosisPINI, M.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S19-S27, issn 0957-5235, SUP2Conference Paper

Workshop II : The future of prolonged thromboprophylaxisHAAS, S; AGNELLI, G; ARCELUS, J. I et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S103-S106, issn 0957-5235, SUP2Conference Paper

Evolution of therapies in deep vein thrombosis managementTEN CATE, J. W.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S5-S10, issn 0957-5235, SUP2Conference Paper

Limitations of established antithrombotic strategiesHAAS, S.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S11-S18, issn 0957-5235, SUP2Conference Paper

Long-term management of deep vein thrombosisPIOVELLA, E; BARONE, M.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S117-S122, issn 0957-5235, SUP2Conference Paper

Clinical limitations of risk assessment modelsLASSEN, M. R; BORRIS, L. C; BACKS, S et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S45-S51, issn 0957-5235, SUP2Conference Paper

Building effective prophylaxis of deep vein thrombosis in the outpatient settingAGNELLI, G; TALIANI, M. R; VERSO, M et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S29-S35, issn 0957-5235, SUP2Conference Paper

Workshop I : The potential role of new therapies in deep vein thrombosis prophylaxisCOHEN, A. T; GALLUS, A. S; HAAS, S et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S99-S102, issn 0957-5235, SUP2Conference Paper

Applying risk assessment models in orthopaedic surgery : overview of our clinical experienceGALLUS, A. S.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S53-S61, issn 0957-5235, SUP2Conference Paper

Applying risk assessment models in general surgery : effective risk stratificationSAMAMA, M.-M.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S79-S84, issn 0957-5235, SUP2Conference Paper

Matching risk with treatment strategies in deep vein thrombosis managementARCELUS, J. I; CAPRINI, J. A; MOTYKIE, G. D et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S37-S43, issn 0957-5235, SUP2Conference Paper

Applying risk assessment models in general surgery : overview of our clinical experienceAGENO, W.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S71-S78, issn 0957-5235, SUP2Conference Paper

Applying risk assessment models in non-surgical patients : effective risk stratificationELDOR, A.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S91-S97, issn 0957-5235, SUP2Conference Paper

Applying risk assessment models in non-surgical patients : overview of our clinical experienceDAVIDSON, B. L.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S85-S89, issn 0957-5235, SUP2Conference Paper

Applying risk assessment models in orthopaedic surgery : effective risk stratificationCOHEN, A. T.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S63-S70, issn 0957-5235, SUP2Conference Paper

Customizing our approach in deep vein thrombosis and pulmonary embolism treatment : overview of our clinical experienceTURPIE, A. G. G.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S107-S115, issn 0957-5235, SUP2Conference Paper

Anticoagulation in acute ischaemic stroke : deep vein thrombosis prevention and long-term stroke outcomesLENSING, A. W. A.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S123-S127, issn 0957-5235, SUP2Conference Paper